Phase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer

por Chew, Helen Kent, Schwartzberg, Lee, Badarinath, Suprith, Rubin, Peter, Shumaker, Grace, Daugherty, James, DeSilvio, Michelle, Mahoney, Janine
Publicado 2014